Side-by-side comparison of AI visibility scores, market position, and capabilities
NASDAQ: SBUX global coffeehouse at $37.184B revenue FY2025 with 40,199 stores and 33.8M Rewards members; CEO Niccol 'Back to Starbucks' operational turnaround competing with Dunkin' and Dutch Bros for premium coffee occasions.
Starbucks Corporation is a Seattle, Washington-based global coffeehouse chain — listed on NASDAQ (NASDAQ: SBUX) — operating 40,199 stores in 88 countries as of fiscal year 2025, serving 100 million customers weekly (14.3 million daily) through company-operated and licensed locations that offer espresso beverages, premium coffee, teas, food items, and merchandise, generating $37.184 billion in revenue in fiscal year 2025 (+2.79% year-over-year) with 33.8 million US Starbucks Rewards members (+4%) and positive comparable store sales growth in Q4 FY2025 after seven consecutive quarters of negative or flat comps under prior leadership. Founded in 1971 in Seattle's Pike Place Market and transformed into the global third-place coffeehouse experience by Howard Schultz, Starbucks holds 40.88% food service market share in the US coffee category.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.